CHIMERIX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.819 EUR | +4.33% |
|
+0.12% | +0.54% |
| 01/05 | Transcript : Chimerix, Inc., Q1 2024 Earnings Call, May 01, 2024 | |
| 01/05 | Chimerix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHIMERIX, INC. | Bio Therapeutic Drugs | +4.33% | +0.12% | - | - | - | 74.84M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- CMRX Stock
- CXF Stock
- Charts Chimerix, Inc.
- Comparison Chart
